Global Patent Index - EP 1100526 A2

EP 1100526 A2 2001-05-23 - USE OF HC gp-39 IN IMMUNE DISEASES

Title (en)

USE OF HC gp-39 IN IMMUNE DISEASES

Title (de)

VERWENDUNG VON HC GP-39 IN IMMUNERKRANKUNGEN

Title (fr)

UTILISATION DE gp-39 DE CARTILAGE HUMAIN DANS DES MALADIES IMMUNES

Publication

EP 1100526 A2 (EN)

Application

EP 99938340 A

Priority

  • EP 99938340 A
  • EP 9905331 W
  • EP 98202471 A

Abstract (en)

[origin: WO0004917A2] The present invention relates to the use of HC gp-39 to prevent inflammatory diseases. More specifically, HC gp-39 or fragments thereof can be used to modulate the reactivity of lymphocytes which are reactive to antigens other than HC gp-39 but which are present in the same tissue as where HC gp-39 is being expressed.

IPC 1-7 (main, further and additional classification)

A61K 38/17

IPC 8 full level (invention and additional information)

A61K 39/00 (2006.01); A61K 38/17 (2006.01); A61P 29/00 (2006.01); A61P 37/02 (2006.01); A61P 43/00 (2006.01)

CPC (invention and additional information)

A61K 38/1709 (2013.01)

Citation (search report)

See references of WO 0004917A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 0004917 A2 20000203; WO 0004917 A3 20000720; WO 0004917 A9 20000824; AU 5287599 A 20000214; EP 1100526 A2 20010523; JP 2002521344 A 20020716

INPADOC legal status


2002-08-07 [18D] APPLICATION DEEMED TO BE WITHDRAWN

- Effective date: 20020131

2001-09-05 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20010720

2001-05-23 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010223

2001-05-23 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

2001-05-23 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO:

- Free text: AL;LT;LV;MK;RO;SI